US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
AMEX
AIM ImmunoTech Inc (AIM)
AIM ImmunoTech Inc (AIM) ニュース

AIM ImmunoTech Inc (AIM)

0.5913

-0.1407

(-19.22%)

終了 6月5日 5:00AM

0.5343

-0.057

( -9.64% )

プレマーケット: 5:08PM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 8-K - Current report

AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness

Video segment examines current Ebola outbreak concerns, unmet need surrounding the Bundibugyo strain and...

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

OCALA, Fla., June 01, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration

Previously published Biosafety Level 4 pre-clinical study showed 100% survival with early treatment following...

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

AIM ImmunoTech Announces $2.4 Million Financing, Including Concurrent Registered Direct Offering and Private Placement

OCALA, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the...

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

AIM ImmunoTech Announces Significant Increase in Stockholder Equity and Extension of Promissory Note Maturity Date to June 2027, Enhancing Financial Flexibility and Supporting Strategic Clinical Priorities

OCALA, Fla., May 19, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial Segment...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

INV4

$0.94+ 😃

$AIM 💹

glenn1919

glenn1919 4日前

AIM......................p/m

INV4

$0.65+ 😃

$AIM 💹

INV4

Bought a little starter. Good luck Jus 🍀

$AIM

JusDePomme

JusDePomme 7日前

https://x.com/AimImmuno

JusDePomme

JusDePomme 1週前

Let's go aim!! Let's make .60 today

JusDePomme

JusDePomme 1週前

PotentiAl spike like otlk

glenn1919

glenn1919 1週前

AIM........................................https://stockcharts.com/sc3/ui/?s=AIM&p=w&b=5&g=0&id=p86431144783

PinkPennies

PinkPennies 1週前

AIM news .. AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration https://finance.yahoo.com/sectors/healthcare/articles/aim-immunotech-announces-emerging-ebola-124700404.html

glenn1919

glenn1919 3月前

AIM.................................https://stockcharts.com/sc3/ui/?s=AIM&p=w&b=5&g=0&id=p86431144783

John_Vallay

John_Vallay 7月前

Boo
You are 100% wrong so far on AIM.

I don't want to hear that the stock will increase. It's been 2-months and your suggestion that AIM was a good investment is 100% wrong.

Unless you are a paid promotor you may not want to give advice because your advice is and was wrong.
If you are a paid promoter you may want to look into SEC laws to make sure you are not PROMOTING a stock without disclosure, YES, even on this message board promotions can be classified as ILLEGAL without disclosure, AND YES, being have been arrested, charged and sentenced and fined for such illegal activity.

BooDog

BooDog 10月前

This one caught my eye for a bottom play. Almost there.

Looks like this company is CRUSHING it. lmao

AIM daily

Like your post.

John_Vallay

John_Vallay 11月前

To All The Nay Sayers that criticize on this board and all other boards I post on - I am ALWAYS proven right.

And YES, I am smarter than most people that criticize me on these boards.

The reason I am smarter is due to some very simple Investment 101 factors: (1) anytime a public company with a market cap less than $500 million has to raise capital they will have dilution and that always leads to lower stock price, (2) when a public company does not have funds invested it means the company should not be public, (3) ALL reverse mergers and SPACS have a never-ending stock price decline among a few other Investment 101 factors.

AND YES - I am always right when the top 3 Investment 101 Factors are adhered to.
AND YES - I make a very good living with my business and even more money investing in small and micro cap companies, but most of my profits are through short positions.
AND YES - I have lost money on some of my investments, but I would say 1 out of 10 investments is a loss, 9 out of 10 is a profit.
AND YES - I pay real taxes that include short term profit taxes on investments.
AND YES - I hope to pay twice as much in taxes every year until I die.

AND NO, all the naysayers that have and will continue to criticize me do not bother or upset me. I try really hard when I post on these boards to let people know about their investment and monies that they are likely to lose because of the 3 investment 101 factors.

I like to think I bring value and can save people money.

makinezmoney

makinezmoney 12月前

$AIM: Added 4k here at $12

Resumed trading.......... gimme $50 today

GO $AIM

makinezmoney

makinezmoney 12月前

$AIM: Halt city going on here............ RS'ed 100:1

And now trading...... $11.94 here on the halt

AIM ImmunoTech Resumes Trading on NYSE Americanhttps://t.co/QsPRSH3tS1 $AIM $AIMI pic.twitter.com/csYYHMo7UQ— AIM ImmunoTech (@AimImmuno) June 17, 2025

This has that moony potential after what happens with big RS's

https://finviz.com/news/82228/aim-immunotech-resumes-trading-on-nyse-american

GO $AIM

Renee

AIMI changed back to AIM. Moved to the AMEX from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions

Renee

AIMI one for 100 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Renee

AIM changed to AIMI. Delisted from the AMEX to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions

BuckBuckBuck

BuckBuckBuck 1年前

This thing is floating belly UP.

lemonhead1de

lemonhead1de 1年前

so,some interesting PR's lately...what is your personal opinion, hope etc. how this will play out in the end for us shareholders?
I know, no one knows, but yeah...what's is your feeling???

2 weeks ago, the PR that they will not proceed with the offering for now, already left many questions...

and then yesterdays double PR about the new director and his contract only for a few month till year end???somehow strange imo...

and the NYCE acceptance for listing compliance...!Top...

so yeah-what could, should, will be next???

A RS(hopefully not) or merger ,buyout etc.?

getting interesting in here:)

81vette

81vette 1年前

3m buys/2m sells/174k In between,big loading and few t trades,this could pop 100% easily

81vette

81vette 1年前

News,no offering until eoy filing(could be Fri)
Zero borrow,ppl saying big news coming,hype might run it up,I only have 10k in it as lotto play

IronBard871

IronBard871 2年前

They're steadily sliding down, but it might still make sense to monitor the situation for a while. Equels Thomas has made modest investments in his company’s stock this year—here’s the insider trading stats for reference: https://prismo.pro/stock/aim. Regardless, shares are purchased with the aim of yielding profit. Could it be they’re preparing for one of their drugs to finally hit the mark?

Prominent Capital

Prominent Capital 2年前

Prominent Capital

Prominent Capital 2年前

Guys what is the potential on this company?

mick

AIM
AIM ImmunoTech Inc
0.265
-0.0508 (-16.09%)
Volume: 527,731
Day Range: 0.261 - 0.3223
Last Trade Time: 12:49:35 PM EDT
Total Trades: 888

Monksdream

Monksdream 2年前

AIM new 52 week low

Monksdream

Monksdream 2年前

AIM new 52 week low

mick

https://www.otcmarkets.com/stock/AIM

mick

https://www.otcmarkets.com/stock/AIM

mick

https://www.otcmarkets.com/stock/AIM

mick

https://www.otcmarkets.com/stock/AIM

mick

https://otcbb.swingtradebot.com/equities/AIM

mick

AIM
AIM ImmunoTech Inc
0.67
0.052 (8.41%)
Volume: 150,500
Day Range: 0.607 - 0.68
Last Trade Time: 8:00:00 PM EDT

mick

AIM
AIM ImmunoTech Inc
0.488
-0.032 (-6.15%)
Volume: 176,585
Day Range: 0.48 - 0.5387
Last Trade Time: 8:00:00 PM EDT

mick

AIM
AIM ImmunoTech Inc
0.4784
0.00 (0.00%)
Volume: 61,433
Day Range: 0.475 - 0.50
Last Trade Time: 8:00:00 PM EDT

mick

https://www.otcmarkets.com/stock/AIM

mick

AIM
AIM ImmunoTech Inc
0.5063
0.0263 (5.48%)
Volume: 62,250
Day Range: 0.47 - 0.49
Last Trade Time: 8:00:00 PM EDT

mick

AIM
AIM ImmunoTech Inc
0.47
0.029 (6.58%)
Volume: 26,623
Day Range: 0.4301 - 0.4586
Last Trade Time: 8:00:00 PM EDT

mick

AIM
AIM ImmunoTech Inc
0.53
0.035 (7.07%)
Volume: 292,608
Day Range: 0.4916 - 0.55
Last Trade Time: 8:00:00 PM EST

mick

AIM
AIM ImmunoTech Inc
0.60
0.06 (11.11%)
Volume: 98,976
Day Range: 0.5301 - 0.5779
Last Trade Time: 8:00:00 PM EST

mick

AIM
AIM ImmunoTech Inc
0.60
0.06 (11.11%)
Volume: 98,976
Day Range: 0.5301 - 0.5779
Last Trade Time: 8:00:00 PM EST

lowfloatwayne

lowfloatwayne 3年前

They have one fda approved drug patent has expired and Ampligen has been denied by fda. This is a good one one to get in after the rs and wait for the bottom. Just like Maple oil

Sesh

This company looks like they have some good potential. I recently watched a doctor from Canada who is convinced by her teams studies that the Covid vaccines cause damage to TLRs 3,7, and 8 causing people to be more susceptible to illness. Their TLR 3 nasal spray might be extremely helpful in this case.

mick

AIM
AIM ImmunoTech Inc
0.34
-0.0067 (-1.93%)
Volume: 196,446
Day Range: 0.322 - 0.35
Last Trade Time: 8:00:00 PM EST

mick

AIM
AIM ImmunoTech Inc
0.6286
0.0708 (12.69%)
Volume: 176,005
Day Range: 0.5678 - 0.5797
Last Trade Time: 8:00:00 PM EDT
Total Trades: 323
AIM Detailed Quote

mick

AIM
Aerosonic Common Stock ($0.40 Par Value)
3.19
0.00 (0.00%)
Volume: -
AIM Detailed Quote

BooDog

This is the AIM I see...

AIM
Bid: 0.70 Ask: 0.7089 Last: 0.7001 Chg ($): -0.0025 Vol: 20.03K
https://finviz.com/quote.ashx?t=AIM

mick

dis is good stuff Phase 2 Study of Ampligen®

mick

Aug-18-22 09:05AM
AIM ImmunoTech Announces Commencement of Phase 2 Study of Ampligen® for the Treatment of Pancreatic Cancer
GlobeNewswire
Aug-16-22 04:05PM
AIM Stockholder Full Value Committee Reiterates Intent to Proceed with Nominations and Proxy Solicitation
GlobeNewswire
-5.50%
Aug-15-22 04:05PM
AIM ImmunoTech Provides Update on Jorgl Activist Group Litigation
Business Wire
08:05AM
AIM ImmunoTech Reports Second Quarter 2022 Financial Results and Provides Corporate Update
GlobeNewswire

Evolve CA Banks and Life...

Fiserv Inc Dl 01

Northern Venture VCT

CAC Large 60 Responsible...

Cypher Metaverse

Red White & Bloom Brands

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。